Insulin Resistance Syndrome and Neuropsychiatric Disease
184,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
92 °P sammeln
  • Gebundenes Buch

The first book of its kind to tie the metabolic syndrome with psychiatric disorders, and the possibility that common antipsychotic treatments may be having an adverse effect on patients. "Insulin Resistance Syndrome and Neuropsychiatric Disorders" describes: - he impact on treatment - psychiatric and cognitive disorders - insulin resistance - the relationship that exists between affective disorders and Alzheimer's disease as a result of insulin resistance - the metabolic syndrome, including its relationships with insulin resistance and cardiovascular disease, as well as new treatments to help…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The first book of its kind to tie the metabolic syndrome with psychiatric disorders, and the possibility that common antipsychotic treatments may be having an adverse effect on patients. "Insulin Resistance Syndrome and Neuropsychiatric Disorders" describes: - he impact on treatment - psychiatric and cognitive disorders - insulin resistance - the relationship that exists between affective disorders and Alzheimer's disease as a result of insulin resistance - the metabolic syndrome, including its relationships with insulin resistance and cardiovascular disease, as well as new treatments to help prevent diabetes Presenting a complete overview and the relationship between metabolic syndrome, insulin resistance, and psychiatric and cognitive disorders, "Insulin Resistance Syndrome and Neuropsychiatric Disorders," will be a welcome update to any psychiatrist's, neurologist's, endocrinologist's, and research scientist's library.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
NATALIE L. RASGON is Professor, Departments of Psychiatry and Behavioral Sciences, Obstetrics and Gynecology, Stanford University, California, and she is Director of the Center for Neuroscience in Women's Health at the Stanford School of Medicine and Stanford Neuroscience Institute. Dr. Rasgon received her M.D. and Ph.D. in Obstetrics and Gynecology and Pathological Physiology from the Central Institute of Postgraduate Medical Education, Central Institute of General Pathology and Pathological Physiology, Academy of Medical Sciences, Moscow, Russia. Dr. Rasgon is the author of over 124 peer-reviewed articles, more than 25 book chapters, and is a reviewer for more than 25 medical journals specific to psychiatry, neuropharmacology, and obstetrics and gynecology.